Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


QUOTED. 23 October 2019. Rob Kowal.

Executive Summary

Medtronic said that the pivotal trial for its implantable cardioverter defibrillator without a transvenous lead has begun. See what Rob Kowal, chief medical officer for Medtronic's cardiac and heart failure business, said about it here.

“We fully believe this is not just a health benefit for individual patients but is also going to be a benefit to the economic system as well, and we will be working to collect the data to support that." – Rob Kowal, chief medical officer for cardiac and heart failure business, Medtronic

Click here for a free trial of Medtech Insight

Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts